Legalised bribery is what some drug reps call their employers' marketing. Despite much publicised recent efforts by drug-industry groups to curb the most egregious ministrations to doctors by reps―curiously, more often than not pretty women―firms still spend billions trying to walk a fine line between product promotion and undue influence. Yet some of the oldest tricks in the marketing book do not seem to pay off as they used to―which is bad news indeed for the drug firms.
展开▼
